Zymeworks Inc.
NASDAQ:ZYMEBiotechnology
Healthcare
$26.86 -1.64%
-$0.38 today
- Market cap
- $1.87B
- Beta
- 1.14
- P/E (TTM)
- -16.6
- EPS (TTM)
- -$1.37
52W Low $11.51High $29.75
Volume 0.99M
Average 0.71M
Balance Sheet
Inspect the capital base behind the business.
Assets
$346.53M
FY 2025 · Annual
-25.2% YoYLiabilities
$78.03M
FY 2025 · Annual
-37.2% YoYEquity
$268.50M
FY 2025 · Annual
-20.7% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 201.87M | 400.91M | 157.56M | 66.1M | 41.16M |
| Short-term Investments | 50.74M | 91.32M | 216.77M | 159.67M | 187.64M |
| Net Receivables | 15.61M | 33.4M | 19.48M | 55.82M | 4.64M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 19.07M | 19.12M | 18.86M | 0 |
| Total Current Assets | 288.22M | 544.71M | 412.93M | 300.45M | 233.44M |
| Property, Plant & Equipment (Net) | 49.77M | 47.65M | 37.54M | 34.32M | 0 |
| Goodwill | 12.02M | 12.02M | 12.02M | 12.02M | 12.02B |
| Intangible Assets | 21.47M | 26.38M | 25.28M | 4.58M | 1.35B |
| Long-term Investments | 886K | 886K | 81.93M | 98.43M | 41.79M |
| Tax Assets | 3.07M | 1.35M | 3.62M | 4.39M | 0 |
| Other Non-current Assets | 13.7M | 15.74M | 7.57M | 8.92M | (13.29B) |
| Total Non-current Assets | 100.91M | 104.02M | 167.95M | 162.64M | 113.09M |
| Total Assets | 389.13M | 648.73M | 580.88M | 463.09M | 346.53M |
| Account Payables | 5.17M | 7.86M | 6.21M | 3.9M | 4.4M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 17.08M | 1.81M | 1.38M | 0 |
| Deferred Revenue | 0 | 2.35M | 3.7M | 25.59M | 2.42M |
| Other Current Liabilities | 11.1M | 16.01M | 8.68M | 7.49M | 9.67M |
| Total Current Liabilities | 71.85M | 95.63M | 55.76M | 88.29M | 42.32M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.57M | 1.79M | 3.3M | 4.76M | 6.03M |
| Deferred Revenue (Non-current) | 32.94M | 30.59M | 32.94M | 14.61M | 14.61M |
| Other Non-current Liabilities | 2.65M | 2.98M | 1.61M | 895K | 278K |
| Total Non-current Liabilities | 68.19M | 60.14M | 60.31M | 36.03M | 35.71M |
| Total Liabilities | 140.04M | 155.77M | 116.07M | 124.32M | 78.03M |
| Common Stock | 741.15M | 906.76M | 1.01B | 1.02B | 1.11B |
| Retained Earnings | (683.1M) | (558.76M) | (677.44M) | (830.34M) | (953.16M) |
| Accumulated OCI | (6.66M) | (6.66M) | (6.6M) | (6.95M) | (6.08M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 249.09M | 492.96M | 464.81M | 338.77M | 268.5M |
| Total Debt | 32.33M | 28.11M | 26.72M | 18.51M | 18.27M |
| Net Debt | (169.53M) | (372.8M) | (130.84M) | (47.6M) | (22.89M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $100.5M |
| Receivables | $413.9M |
| Other Current | $18.1M |
| Total Current Assets | $532.4M |
| PP&E (Net) | $63.5M |
| Goodwill | $116.4M |
| Intangible Assets | $431.0M |
| Tax Assets | $5.8M |
| Other Non-current | $27.2M |
| Total Non-current Assets | $644.0M |
| Total Assets | $1.2B |
Analysis
Selected assets total $1.2B for Latest. The largest visible component is Intangible Assets at $431.0M, about 36.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 9, 2026 | |
| 8-K/A | 8-K/A filing | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| ARS | ARS filing | Oct 26, 2026 | |
| DEFA14A | DEFA14A filing | Oct 26, 2026 |
How much cash does ZYME have?
Zymeworks Inc. (ZYME) reported $41.16M in cash and equivalents in fiscal 2025.
How much debt does ZYME carry?
Zymeworks Inc. (ZYME) reported $18.27M of total debt, with net debt of -$22.89M.
Continue the stock analysis
Jump to another research area for this company.